Family Med Medical News about Hodgkin lymphoma

Become a Member Today!
Register

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma
Leukemia and Lymphoma, 11/04/09

Cavalieri E et al. – BEACOPP is an effective regimen for both refractory/relapsed patients with HL after first–line treatment (Group A) and for patients relapsing after a PBSCT (Group B) with a 3–year probability of overall survival, progression–free survival, and cumulative incidence of relapse of 90, 50, and 33.3% in Group A, and 61, 31, and 37.5% in Group B, respectively.

<< Previous
Addition of rituximab to cyclophosphamide, doxorubicin,...

Next >>
Person-Environment Interactions Contributing to Nursing Home...

Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry.
Annals of Rheumatic Diseases, 10/22/09 Relevance Score: 70%

Sperm quality before treatment in patients with early stage Hodgkin lymphoma enrolled in EORTC-GELA Lymphoma Group trials
Haematologica, 10/27/09 Relevance Score: 69%

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study : The Lancet Oncology
The Lancet Oncology - Online First, 10/12/09 Relevance Score: 69%

Hepatocellular carcinoma infiltrated with non-Hodgkins lymphoma: Report of a case
Surgery Today, 11/11/09 Relevance Score: 68%

Primary lymphoma of the colon
Saudi Journal of Gastroenterology, 10/05/09 Relevance Score: 68%